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Abstract 
The importance of the working document is that it allows the analysis of the information and the status of 
cases associated with (SARS-CoV-2) COVID-19 as open data at the municipal, state and national level, with a 
daily record of patients, according to a age, sex, comorbidities, for the condition of (SARS-CoV-2) COVID-19 
according to the following characteristics: a) Positive, b) Negative, c) Suspicious. Likewise, it presents 
information related to the identification of an outpatient and / or hospitalized patient, attending to their 
medical development, identifying: a) Recovered, b) Deaths and c) Active, in Phase 3 and Phase 4, in the five 
main population areas speaker of indigenous language in the State of Veracruz - Mexico. The data analysis is 
carried out through the application of a data mining algorithm, which provides the information, fast and 
timely, required for the estimation of Medical Care Scenarios of (SARS-CoV-2) COVID-19, as well as for know 
the impact on the indigenous language speaking population in Veracruz. For this purpose, the following study 
zones are presented: a) Totonacapan Zone, b) Huasteco from the Tantoyuca Zone, c) Otomi from the 
Inxhuatlan de Madero Zone, d) Nahuatl from the Zongolica Zone, e) Nahuatl from the Chicontepec Zone, f) 
Nahualt from the Pajapan Zone and g) Popoluca from the Soteapan Zone. This data article presents the 
information as of August 1, 2020 corresponding to the Huasteco Area. 
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Specifications Table  
Subject Infectious Diseases 
Specific subject area Information from the Viral Respiratory Diseases Epidemiological 
Surveillance System for (SARS-CoV-2) COVID-19 in Mexico corresponding 
to the Huasteco from the Tantoyuca Zone. 
Type of data Table 
Figure 
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How data were acquired Government of Mexico. Health Secretary. Databases Covid-19 México  
https://datos.gob.mx/busca/dataset/informacion-referente-a-casos-
covid-19-en-mexico/resource/e8c7079c-dc2a-4b6e-8035-08042ed37165 
Instruments:  
Software Orange Data Mining version 3.26.0 https://orange.biolab.si 
Make and model and of the instruments used: 
Algorithm for the identification of patients according to following 
characteristics: a) Positive, b) Negatives, c) Suspects. Likewise, it presents 
information regarding the identification of an outpatient and / or 
hospitalized patient, attending to their medical development, identifying: 
a) Recovered, b) Deaths and c) Assets 
Data format The information is presented in raw in CVS format, the Ministry of Health 
of Mexico since April 14, 2020 published the cases associated with (SARS-
CoV-2) COVID-19 as open data. The data processing corresponds to the 
records on the epidemic (SARS-CoV-2) COVID-19 at 1 August 2020. The 
treatment of the information is carried out through the application 
software for data mining Orange version 3.26.0, in which the algorithm for 
the analysis of information is filtered to present the current scenario in 
Huasteco from the Tantoyuca Zone in Mexico of the SARS-CoV-2 (COVID 
19). 
 
Parameters for data 
collection 
The information is presented at the municipal, state and national levels, 
with a daily registry of patients, according to age, sex, comorbidities, for 
the condition of (SARS-CoV-2) COVID-19 according to the following 
characteristics: a) Positive, b) Negatives, c) Suspects. Likewise, it presents 
information regarding the identification of an outpatient and / or 
hospitalized patient, attending to their medical development, identifying: 
a) Recovered, b) Deaths and c) Assets. 
Study area The municipalities that comprise Huasteco from the Tantoyuca  Area are: 
Naranjos Amatlán, Cerro Azul, Chinampa de Gorostiza, Chontla, Ozuluama 
de Mascareñas, Panuci, Pueblo Viejo, Tamiahua, Tantoco, Tantima, 
Tantoyuca, Tempoal, Tuxpan and El Higo. 
Description of data 
collection 
This information is filtered to present the current scenario in Huasteco 
from the Tantoyuca Area  in Mexico of the SARS-CoV-2 (COVID 19) in a 
fast and timely manner, to support public decision-making in health 
matters. 
Data source location Institution: Universidad Veracruzana / Instituto de Investigaciones y 
Estudios Superiores Económicos y Sociales 
Country: México 
Data accessibility Raw data can be retrieved from the Github repository 
https://github.com/CMedelR/dataCovid19/edit/master/README.md 
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Value of the Data 
 
• The Algorithm for the identification of patients (SARS-CoV-2) COVID 19 in Mexico allows to analyze 
at the municipal, state and national level, the registry of patients, according to age, sex, 
comorbidities, for condition of (SARS-CoV-2) COVID-19 according to the following characteristics: a) 
Positive, b) Negative, c) Suspicious, as well as presenting information on the identification of an 
outpatient and / or hospitalized patient, attending to their medical development, identifying: a) 
Recovered, b ) Deaths and c) Assets, in Phase 3 and Phase 4, in a fast and timely manner, to support 
public decision-making in health matters. 
• Taking into account their strategic roles in public health and researchers can use the data from this 
study to identify the action scenario for decision-making in the combat of (SARS-CoV-2) COVID 19 in 
Phase 3 and Phase 4 corresponding to the Huasteco from the Tantoyuca Area. 
• The importance of data analysis is that it allows identifying cases (SARS-CoV-2). COVID-19 in Mexico 
is concentrated daily and knowing the impact on the population and allows preparing action scenarios 
to make public health policy decisions to combat SARS-CoV-2) COVID-19 in the main five areas that 
concentrate the speaking population of Nahuatl, Totonaco, Huasteco, Popoluca, Otomi in Veracruz 
Mexico. 
 
Data Description 
 
The source of information on the number of registered cases of (SARS-CoV-2) COVID-19 at 1 August 2020 for 
Mexico comes from the website https://datos.gob.mx/busca/dataset/informacion-referente-a-casos-
covid-19-en-mexico by the Ministry of Health, with the participation of the National Council for Science and 
Technology (CONACYT), the Center for Research in Geospatial Information Sciences (CENTROGEO), the 
National Laboratory for Geo-Intelligence (GEOINT), the Data Laboratory of the National Laboratory for 
Geointelligence (DataLab), where the registry of COVID-19 cases (SARS-CoV-2) COVID-19 is concentrated, and 
is the official means of communication and information on the epidemic in the Huasteco from the Tantoyuca 
Area in Mexico. 
 
The information of the cases (SARS-CoV-2) COVID-19 in Mexico is concentrated on a daily basis since April 19, 
2020, communication and official information on the epidemic in Mexico, the data are presented at the 
municipal, state and national levels, with a daily registry of patients, according to age, sex, comorbidities, for 
the condition of (SARS-CoV-2) COVID-19 according to the following characteristics: a) Positive, b) Negatives, 
c) Suspects. Likewise, it presents information regarding the identification of an outpatient and / or 
hospitalized patient, attending to their medical development, identifying: a) Recovered, b) Deaths and c) 
Assets. The data processing corresponds to the records on the epidemic (SARS-CoV-2) COVID-19 at 1 August 
2020. The treatment of the information is carried out through the application software for data mining and 
visual programming Orange Data Mining version 3.26.0.  Orange Data Mining is a machine learning and data 
mining suite for data analysis through Python scripting and visual programming. [1] 
 
According to (WHO, 2020) the (SARS-CoV-2) COVID-19 disease pattern presents 4 scenarios identified from 
the confirmation of Laboratory Diagnosis: a) Not Infected or b) Infected, in this finally, the following categories 
are observed, taking into account age and specific comorbidities in each case: a) Mild Infection, b) Moderate 
Infection, c) Severe Infection and d) Critical Infection. 
 
Depending on the category observed in Patients who have a Confirmation of Infected, as in the case of a) or 
b) it can assume the character of Outpatient, so the strategy is isolation or "quarantine" at home, where the 
result It is hoped that he will recover. Regarding the Patients who have a Confirmation of Infected, in 
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categories c) and d) they assume the character of Hospitalized Patient, with a probability of requiring care in 
Intensive Care Units and requiring Intubation, and where it is hoped to save as many patients as possible. 
 
The importance of the research is that it allows identifying the action scenario for making public health policy 
decisions to combat CO(SARS-CoV-2) COVID-19, since they consider the following states of process in medical 
treatment, in order to carry out the Estimate of Scenarios for Medical Care of the (SARS-CoV-2) COVID-19  
under the following premises of hospital care: 
1. A patient with a positive (SARS-CoV-2) COVID-19 laboratory diagnosis can be considered: a) Outpatient, 
or b) Hospitalized. 
2. If the (SARS-CoV-2) COVID-19 Positive patient is Hospitalized, the following should be considered: a) 
Enter the Intensive Care Unit or b) Do not enter the Intensive Care Unit. 
3. If the (SARS-CoV-2) COVID-19 Positive patient is Hospitalized and Entered into the Intensive Care Unit, 
the following should be considered: a) The patient requires intubation or b) The patient does NOT require 
intubation. 
 
Methods 
 
The information is presented in raw in CVS format, the Ministry of Health of Mexico. The data processing 
corresponds to the records on the epidemic (SARS-CoV-2) COVID-19 at 1 August 2020. The treatment of the 
information is carried out through the application software for data mining Orange version 3.26.0, in which 
the algorithm for the analysis of information are developed and it is filtered to present the current scenario 
in Mexico of the SARS-CoV-2 (COVID 19). In this way, the algorithm that is presented allows us to project the 
requirements for the use of installed infrastructure in the face of the growing requirement for patient care 
Positive (SARS-CoV-2) COVID-19, allowing the identification of scenarios at the national, state and municipal 
levels. The construction of the algorithm is based on the following definitions. 
 
Definition 1: Total Patients to consider in Model (SARS-CoV-2) COVID-19.- It is the number of total patients 
according to the confirmatory laboratory result or not of (SARS-CoV-2) COVID-19). 
Be: 
TP SARS-CoV-2 i j = Total patients according to (SARS-CoV-2) COVID-19 confirmatory laboratory result  
Which consists of: 
TP SARS-CoV-2 i j = (P + SARS-CoV-2 i j) + (P- SARS-CoV-2 i j) + (Px SARS-CoV-2 i j),  where: i = State, j = 
Municipality 
Of which: 
P+ SARS-CoV-2 i j = Patient with a positive (SARS-CoV-2) COVID-19 result in the State, Municipality 
P-  SARS-CoV-2 i j = Patient with negative (SARS-CoV-2) COVID-19 result in the State, Municipality 
Px  SARS-CoV-2 i j = Patient with pending confirmation (SARS-CoV-2) COVID-19 in the State, Municipality 
 
Definition 2: Identification of a suspected (SARS-CoV-2) COVID-19 case.- This is the patient who undergoes 
an initial qualification according to the initial diagnostic characteristics indicated in the case definitions for 
surveillance by the World Health Organization for primary care of (SARS-CoV-2) COVID-19 cases. 
Be: 
CsCOVID 19 (SARS-CoV-2) = Patient with initial classification as a suspected case of (SARS-CoV-2) COVID-19 
Where: 
Cs (SARS-CoV-2) COVID-19 = Cs (SARS-CoV-2) COVID-19 Type 1 + Cs (SARS-CoV-2) COVID-19  Type 2 + Cs (SARS-
CoV-2) COVID-19  Type 3 
Of which: 
According to the World Health Organization, there are 3 categories (identified as Type 1, Type 2 and Type 3) 
to identify suspected cases of (SARS-CoV-2) COVID-19, defined below: 
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1. Cs (SARS-CoV-2) COVID-19 Type 1.- Is a patient with acute respiratory disease (fever and at least one 
sign / symptom of respiratory disease, with no other aetiology that fully explains the clinical 
presentation and a history of travel or residence in a country / area or territory that reports local 
transmission of COVID-19 disease during the 14 days prior to the onset of symptoms. 
2. Cs (SARS-CoV-2) COVID-19 Type 2.- He is a patient with an acute respiratory disease, who has been in 
contact with a confirmed or probable COVID-19 case in the last 14 days before the onset of symptoms. 
3. Cs (SARS-CoV-2) COVID-19 Type 3.- Is a patient with severe acute respiratory infection (fever and at 
least one sign / symptom of respiratory illness (eg cough, shortness of breath) and requiring 
hospitalization and without another etiology that fully explains the clinical presentation. 
 
Definition 3: Total Patients to consider in the (SARS-CoV-2) COVID-19  Model .- It is the number of total 
patients according to the confirmatory laboratory result or not of (SARS-CoV-2) COVID-19). 
Be: 
TP SARS-CoV-2 i j = Total patients according to confirmatory laboratory result or not of (SARS-CoV-2) COVID-
19  
Which consists of: 
TP SARS-CoV-2 i j = (P + SARS-CoV-2 i j) + (P- ARS-CoV-2 i j) + (Px ARS-CoV-2 i j) , where: i = State, j = 
Municipality 
Of which: 
P + SARS-CoV-2 i j = Patient with a positive (SARS-CoV-2) COVID-19 result in the State, Municipality 
P- ARS-CoV-2 i j = Patient with negative (SARS-CoV-2) COVID-19 result in the State, Municipality 
Px ARS-CoV-2 i j = Patient with pending confirmation (SARS-CoV-2) COVID-19 in the State, Municipality 
 
Definition 4: Positive Patients for (SARS-CoV-2) COVID-19 i j.- It is the number of patients with laboratory 
results with positive confirmation for (SARS-CoV-2) COVID-19 i j . 
It has: 
P + SARS-CoV-2 i j = Patient with a positive (SARS-CoV-2) COVID-19 result in the State, Municipality 
 
Definition 5.- Medical Treatment Strategy for a patient with positive laboratory confirmation for (SARS-CoV-
2) COVID-19 i j .- It is the Action Plan in Medical Treatment for a patient with positive laboratory confirmation 
for SARS-CoV-2 in attention to your degree of infection and comorbidities present that is channeled to 
determine the Physician. 
 
According to the Strategy of Medical Care required for Patients with a Positive SARS-CoV-2 Result, according 
to their degree of identified infection, they have the following. 
Be: 
ET P + SARS-CoV-2 i j = Medical Treatment Strategy P + SARS-CoV-2 i j 
 
The medical treatment for a patient with a positive laboratory result for (SARS-CoV-2) COVID-19, based on 
the Medical Treatment Strategy (ETM P + SARS-CoV-2 ij), based on his degree of infection and present 
comorbidities, poses two action scenarios : i) Outpatient (SARS-CoV-2) COVID-19  patient or ii) Hospitalized 
(SARS-CoV-2) COVID-19  patient. 
Be: 
i) Outpatient COVID19 patient. 
      P + SARS-CoV-2 i j Outpatient = Positive (SARS-CoV-2) COVID-19 with Outpatient mode in the State, 
Municipality 
ii) COVID19 Patient Hospitalized. 
      P + SARS-CoV-2 i j Hospitalized = Positive (SARS-CoV-2) COVID-19 with modality Hospitalized in the State, 
Municipality 
where: 
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Depending on the degree of infection (I1, I2 or I3), the Hospitalized (SARS-CoV-2) COVID-19  Patient may 
require: i) Access to the Intensive Care Area without Intubation or ii) Access to the Intensive Care Area with 
Intubation. 
 
Definition 6.- Patients with a Positive (SARS-CoV-2) COVID-19 Result Hospitalized with Access to the 
Intensive Care area.-  It is the number of Patients with a Positive SARS-CoV-2 Result Hospitalized with Access 
to the Intensive Care area, according to its degree of infection. 
Be: 
P + SARS-CoV-2 i j Hospital Intensive Care = Positive (SARS-CoV-2) COVID-19 with modality 
Hospitalized in the State, Municipality 
Definition 7.- Patients with a positive (SARS-CoV-2) COVID-19 result Hospitalized with access to the Intensive 
Care Area with Intubation.-  It is the number of Patients with a Positive (SARS-CoV-2) COVID-19 Result 
Hospitalized with Access to the Intensive Care area with Intubation. 
Be: 
P + SARS-CoV-2 i j Hospital Intensive Care with Intubation = Positive (SARS-CoV-2) COVID-19 with Hospitalized 
modality and intubation in the State, Municipality. 
 
Definition 8.- P + SARS-CoV-2 i j Deaths.- Deaths of Patients with a positive result for SARS-CoV-2. Deaths are 
all those positive to (SARS-CoV-2) COVID-19 where one is indicated in the data record (DATE_DEF other than 
the value "99-99-9999"). 
 
Definition 9.- (SARS-CoV-2) COVID-19 case fatality rate.- It is the proportion of people who die from (SARS-
CoV-2) COVID-19 among the Patients with a positive (SARS-CoV-2) COVID-19 result in a given period and area. 
Be: 
TL SARS-CoV-2 i j = (SARS-CoV-2) COVID-19 case fatality rate 
Where: 
(SARS-CoV-2) COVID-19 case fatality rate = [(Deaths of Patients with a Positive (SARS-CoV-2) COVID-19 Result 
in the State or Municipality) / (Total of Patients with a Positive (SARS-CoV-2) COVID-19 result in the State or 
Municipality)] x 100 
Of which: 
DP+ SARS-CoV-2 i j = Deaths of Patients with a positive (SARS-CoV-2) COVID-19 result in the State / 
Municipality 
And: 
P+ SARS-CoV-2 i j = Total Patients with a positive (SARS-CoV-2) COVID-19 result in the State / Municipality 
So: 
TL SARS-CoV-2 i j = [D P + SARS-CoV-2 i j / P + SARS-CoV-2 i j] x 100 
 
The data processing corresponds to the records on the epidemic (SARS-CoV-2) COVID-19 at 1 August 2020. 
The treatment of the information is carried out through the application software for data mining Orange 
version 3.26.0, in which the algorithm for the information analysis are developed. (See Figure 1, below). 
According to information from the Ministry of Health, the following records are available at the national level:   
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Figure 1. Algorithm for the identification of patients 
(SARS-CoV-2) COVID 19 in the Huasteco from the Tantoyuca Area 
in Mexico  Orange Data Mining version 3.26.0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Self made. With information provided by the Ministry of Health as of 1 June 2020 and Orange 
Data Mining version 3.25.1 
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According to information from the Ministry of Health in Mexico, the following records are available at the 
national level: 
 
1. The total number of cases in Mexico as of august 1, 2020, is 999,697 cases of which, based on the 
confirmatory or non-laboratory result for (SARS-CoV-2) COVID-19, the following classification is 
obtained: a ) 434,193 patients with a positive result for (SARS-CoV-2) COVID-19, b) 477,733 patients 
with a non-positive result for (SARS-CoV-2) COVID-19 and c) 87,771 patients with a pending result to 
determine (SARS-CoV -2) COVID-19. (See table 1) 
2. The number of patients with a positive (SARS-CoV-2) COVID-19 result is 434,193 of which:  a) 316,860 
are care outpatients and b) 117,333 are hospitalized patients. (See table 2) 
3. The total number of patients (SARS-CoV-2) COVID-19 hospitalized (include positive and non positive 
results) is 192,214 of whom 78,088 are women and 114,126 are men. (See Table 3) 
4. The total number of hospitalized patients with a positive result for (SARS-CoV-2) COVID-19 is 117,219, 
of whom: a) 9,400 patients enter the intensive care unit; while b) 107,819 patients do not enter the 
intensive care unit. (See Table 4) 
5. Only 4,874 Hospitalized with a positive (SARS-CoV-2) COVID-19 patients admitted to the intensive 
care unit required intubation; while 4,526 patients did not require intubation. (See Table 5) 
6. Likewise, to date 42,158 deaths from positive (SARS-CoV-2) COVID-19 patients have been registered 
nationwide, of which 3,486 deaths corresponded to Positive (SARS-CoV-2) COVID-19 patients who 
were in intensive care and intubation and 38,672 corresponded to (SARS-CoV-2) COVID-19 positive 
patients who were not in intensive care. (See Table 6). 
7. The fatality rate of patients with a positive result for SARS-CoV-2) COVID-19  at nationwide as of 
august 1, 2020, is estimated at 10.93%.  The five states that registered the highest fatality rates as of 
August 1, 2020 are the following: a) Morelos with a rate of 2039%, b) Baja California with 19.67%, c) 
Sinaloa with a rate of 17.46% , d) Colima with a rate of 17: 00% and e) State of Mexico with a rate of 
15.37%. For its part, the State of Veracruz registered a rate of 13.20% while Mexico City registered a 
rate of 9.75%  (See Table 7). 
8. Figure 1 shows the main comorbidities identified in hospitalized patients with a positive result for 
(SARS-CoV-2) COVID-19, nationwide as of August 1, 2020. 
9. In the State of Veracruz, the total number of cases related to (SARS-CoV-2) COVID-19 as of August 1, 
2020 is 34,904  of which: a) 21,582 correspond to patients with positive confirmation for (SARS-CoV- 
2) COVID-19, b) 10,518 are patients with a negative result for (SARS-CoV-2) COVID-19 and c) 2,804 
are patients with results pending confirmation. (See Table 8).   
10. In the State of Veracruz, 4.97% of all patients with a positive result for (SARS-CoV-2) COVID-19 are 
concentrated at the national level as of August 1, 2020. (See Table 1 and Table 8).   
11. For its part, in the Huasteco from the Tantoyuca Area the total number of cases related to (SARS-CoV-
2) COVID-19 as of August 1, 2020 is 1,723 of which: a) 987correspond to patients with positive 
confirmation for (SARS- CoV- 2) COVID-19, b) 534 are patients with a negative result for (SARS-CoV-
2) COVID-19 and c) 202 are patients with results pending confirmation. (See Table 9). 
12. The percentage of patients with a positive result for (SARS-CoV-2) COVID-19 is 1.92% with respect to 
the total number of cases registered in the Huasteco from the Tantoyuca Area (See Table 9 and Table 
10). 
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According to information from the Ministry of Health, in the Huasteco from the Tantoyuca Area the 
following records are available at the national level: 
 
1. The number of patients with a positive (SARS-CoV-2) COVID-19 result is 2,661 of which: a) 1,129 
are women and b) 1,532 are men. The total number of women with a positive (SARS-CoV-2) 
COVID-19, only 11 are women who speak the indigenous language and 1,118 are women who do 
not speak the indigenous language. On the other hand, the total number of men with a positive 
(SARS-CoV-2) COVID-19, 8 are men who speak the indigenous language and 1,524 are men who 
do not speak the indigenous language. (See Table 10). 
2. Of the 987 positive cases for (SARS-CoV-2) COVID 19, only 8 correspond to patients who speak an 
indigenous language and 979 are patients who are not speakers of an indigenous language. (See 
Table 11)  
3.  From the 987 patients with (SARS-CoV-2) positive COVID-19, according to their primary hospital 
care, there are: a) 581 are patients who did not require hospitalization and b) 406 are patients 
who required hospitalization. From the 963 patients with (SARS-CoV-2) COVID-19 positive who 
were hospitalized: a) 7 correspond to speakers of the indigenous language and b) 628 are patients 
who do not speak the indigenous language. The 987 patients with (SARS-CoV-2) COVID-19 positive 
who were not hospitalized, only 7 were patients speaking the indigenous language hospitalized  
and  399 were patients who did not speak the indigenous language hospitalized. (See Table 12). 
4. From the 8 patients who speak the indigenous language, these come from: Panuco 3 patient and 
Tantoyuca 5. (See Table 13) 
5. From the 7 hospitalized (SARS-CoV-2) COVID-19 positive patients: a) 0 patients enter the Intensive 
Care Unit; while b) 7 patients do not enter the Intensive Care Unit. Only  2 Hospitalized (SARS-
CoV-2) COVID-19 Positive patients required intubation in Panuco. (See Table 14). 
6. As of August 1, 2020 there have been 2 deaths of hospitalized patients (SARS-CoV-2) COVID-19 
whose results were positive and were indigenous language speakers in the Huasteco from the 
Tantoyuca Area. (See Figure 2, at the end of the section, where the associated comorbidities of 
the indigenous language-speaking patients who died in the Huasteco from the Tantoyuca Area, 
as August 1 2020.  
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Table 1. Total number of cases in Mexico 1 August 2020, 
According to Sex and Result at (SARS-CoV-2) COVID-19 
  
 Sex  
Result    Women          Men             Total  
Positive (SARS-CoV-2) COVID-19  203,284   230,909   434,193   
No positive (SARS-CoV-2) COVID-19  254,331   223,402   477,733  
Pending result  43,466   44,305  87,771  
Total   501,081   498,616   999,697   
Source: Government of Mexico. Health Secretary. Information from the 
Epidemiological Surveillance System for Viral Respiratory Diseases 1 August 
2020 
 
 
Table 2. Total number of cases in Mexico as of August 1, 2020, according to 
type of patient and result in (SARS-CoV-2) COVID-19 
  
 Patient type  
Result  Ambulatory         Hospitalized             Total  
Positive (SARS-CoV-2) COVID-19  316,860   117,333   434,193   
No positive (SARS-CoV-2) COVID-19  418,514   59,219  477,733  
Pending result  72,109   15,662  87,771  
Total   807,483   192,214   999,697   
Source: Government of Mexico. Health Secretary. Information from the 
Epidemiological Surveillance System for Viral Respiratory Diseases 1 August 
2020 
 
 
Table 3. Total number of cases in Mexico as of August 1, 2020, according to sex 
and type of patient  
  
 Patient type  
Sex  Ambulatory         Hospitalized  Total  
Women  422,993   78,088   501,081   
Men  384,490   114,126  498,616  
Total   807,483   192,214   999,697   
Source: Government of Mexico. Health Secretary. Information from the 
Epidemiological Surveillance System for Viral Respiratory Diseases 1 August 
2020 
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Table 4. Total number of cases in Mexico as of August 1, 2020, according 
type of patient and  Intensive care unit  
  
Patient type  Intensive care unit 
        No Intensive care 
 unit  Total  
Hospitalized  9,400   107,819  117,219   
Source: Government of Mexico. Health Secretary. Information from the 
Epidemiological Surveillance System for Viral Respiratory Diseases 1 August 
2020 
 
 
Table 5. Total number of cases in Mexico as of August 1, 2020, according to 
hospitalized patient in intensive care unit and intubation condition 
     
Patient type  Intubated patient 
        No Intubated 
patient  Total  
Hospitalized 
intensive care 
unit 
 4,874   4,526  9,400  
 
Source: Government of Mexico. Health Secretary. Information from the 
Epidemiological Surveillance System for Viral Respiratory Diseases 1 August 
2020 
 
 
Table 6. Number of deceased patients with positive COVID-19 (SARS-
CoV-2), nationwide and according to hospital care condition  
as of August 1, 2020 
  
Patient type  Women Men  Total  
 
At the national 
level 
 14,878   27,280  42,158  
 
Intensive care 
unit patients with 
intubation 
 1,085   2,401  3,486  
 
% Deceased 
patients requiring 
care in intensive 
care units and 
intubation, by sex 
 7.3%   8.0%  8.3%  
Source: Government of Mexico. Health Secretary. Information from the 
Epidemiological Surveillance System for Viral Respiratory Diseases 1 August 2020 
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Table 7. (SARS-CoV-2) COVID-19 fatality rate by state in Mexico 
as of August 1, 2020 
 
 
Source: Own elaboration with Government of Information from the Mexico. Health 
Secretary. Epidemiological Surveillance System for Viral Respiratory Diseases as of 
August 1, 2020 
 
 
 
 
 
 
 
Estado Total deceased Covid positives 19 Case fatality rate
1 Aguascalientes 257                            4,120                                 6.24%
2 Baja California 2,674                       13,594                              19.67%
3 Baja California Sur 182                            4,498                                 4.05%
4 Campeche 500                            4,588                                 10.90%
5 Chiapas 645                            13,116                              4.92%
6 Chihuahua 194                            1,875                                 10.35%
7 Ciudad de México 7,244                       74,314                              9.75%
8 Coahuila de Zaragoza 967                            5,775                                 16.74%
9 Colima 904                            5,317                                 17.00%
10 Durango 288                            4,167                                 6.91%
11 Guanajuato 1,009                       21,378                              4.72%
12 Guerrero 1,415                       11,032                              12.83%
13 Hidalgo 1,033                       6,901                                 14.97%
14 Jalisco 1,549                       13,313                              11.64%
15 México 8,225                       53,513                              15.37%
16 Michoacán de Ocampo 780                            9,910                                 7.87%
17 Morelos 836                            4,101                                 20.39%
18 Nayarit 391                            3,518                                 11.11%
19 Nuevo León 1,118                       18,032                              6.20%
20 Oaxaca 968                            10,673                              9.07%
21 Puebla 2,446                       20,355                              12.02%
22 Querétaro 449                            3,726                                 12.05%
23 Quintana Roo 1,015                       7,840                                 12.95%
24 San Luis Potosí 522                            9,921                                 5.26%
25 Sinaloa 2,230                       12,774                              17.46%
26 Sonora 1,949                       17,890                              10.89%
27 Tabasco 1,988                       21,747                              9.14%
28 Tamaulipas 1,008                       17,130                              5.88%
29 Tlaxcala 713                            4,627                                 15.41%
30 Veracruz de Ignacio de la Llave 2,849                       21,582                              13.20%
31 Yucatán 875                            10,098                              8.67%
32 Zacatecas 249                            2,768                                 9.00%
Total 47,472                    434,193                           10.93%
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Figure 1 Comorbidities identified in hospitalized patients with a positive 
result for (SARS-CoV-2) COVID-19, nationwide as  
of August 1, 2020 
 
 
                                                                                                                                                                                                               Sex         Age 
 
                                                                                                                                                                    Sex =1 Women, Sex = 2 Men 
 
Source: Own elaboration with Government of Information from the Mexico. 
Health Secretary. Epidemiological Surveillance System for Viral Respiratory 
Diseases as of August 1, 2020 
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Table 8. Total number of cases in Veracruz State as of August 1, 2020, 
According to Sex and Result at (SARS-CoV-2) COVID-19 
 
Sex  
Result Women Men Total 
Positive (SARS-CoV-2) COVID-19     9,250    12,332 21,582 
No positive (SARS-CoV-2) COVID-19     5,663      4,865 10,518 
Pending result     1,285      1,519 2,804 
Total     16,198      18,706 34,904 
Source: Own elaboration with Government of Information from the 
Mexico. Health Secretary. Epidemiological Surveillance System for Viral 
Respiratory Diseases as of August 1, 2020 
 
 
Table 9. Total number of cases in Huasteco from the Tantoyuca Area in 
Mexico as of August 1, 2020, According to Sex and Result at (SARS-CoV-
2) COVID-1 
 
Sex  
Result Women Men Total 
Positive (SARS-CoV-2) COVID-19      343      644 987 
No positive (SARS-CoV-2) COVID-19      264      270 534 
Pending result         86       116 202 
Total        693     1,030 1,723 
Source: Own elaboration with Government of Information from the 
Mexico. Health Secretary. Epidemiological Surveillance System for Viral 
Respiratory Diseases as of August 1, 2020 
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Table 10. Total number of cases with result positive at (SARS-CoV-2) 
COVID-19 in the Huasteco from the Tantoyuca Area in Mexico as of 
August 1, 2020, according to sex, indigenous language speaker status 
 and  
 
  
Result Women Men Total 
Indigenous language speaker          11            8 19 
Non-indigenous language speaker     1,105     1,502 2,607 
Not specified          13          22 22 
Total        1,129       1,532  2,661 
Source: Own elaboration with Government of Information from the 
Mexico. Health Secretary. Epidemiological Surveillance System for Viral 
Respiratory Diseases as of August 1, 2020, 
 
 
 
Table 11. Total number of cases according to the result for (SARS-CoV-2) 
COVID-19 in the Huasteco of the Tantoyuca area in Mexico as of August 1, 
2020, according to sex and condition of speaker of an indigenous language 
  
Result                              Positive (SARS- 
                                          CoV-2) COVID 19 
Non Positive 
(SARS-CoV-
2) COVID-19 
Pending 
result    
Indigenous language speaker          8            8 3 
Non-indigenous language speaker      963     1,044 600 
Not specified         16          16 3 
Total         987       1,068  606 
Source: Own elaboration with Government of Information from the 
Mexico. Health Secretary. Epidemiological Surveillance System for Viral 
Respiratory Diseases as of August 1, 2020, 
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Table 12. Total number of cases with result positive at (SARS-CoV-2) COVID-19 
in the Huasteco from the Tantoyuca Area in Mexico as of August 1, 2020, 
according to primary hospital care condition and indigenous language speaker 
status 
 
  
Result                Non   Hospitalized Hospitalized Total 
Indigenous language speaker             1           7 8 
Non-indigenous language speaker         576       387 963 
Not specified             4         12 16 
Total           581         406 987 
Source: Own elaboration with Government of Information from the Mexico. Health 
Secretary. Epidemiological Surveillance System for Viral Respiratory Diseases as of 
August 1, 2020 
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Table 13. Total number of cases with result positive at (SARS-CoV-2) 
COVID-19   in the Huasteco from the Tantoyuca Area in Mexico as of 
August 1, 2020, according to primary indigenous language speaker 
status and municipality 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Own elaboration with Government of Information from the Mexico. 
Health Secretary. Epidemiological Surveillance System for Viral Respiratory 
Diseases as of August 1, 2020 
 
 
 
 
 
 
 
 
 
 
 
 
Municipality Speak 
indigenous 
language 
Non 
Speak 
indigenous 
language  
Not specified Total 
 
Naranjos Amatlán 
 
                  0 
 
33 
 
0 
 
33 
Cerro Azul                    0 31 1 32 
Chinampa de 
Gorostiza 
 
0 
 
3 
 
0 
 
3 
Chontla 0 0 0 0 
Ozuluama de 
Mascareñas 
 
0 
 
7 
 
0 
 
7 
Panuco 3 236 1 240 
Pueblo Viejo 0 52 2 54 
Tamiauhua 0 8 1 9 
Tancoco 0 2 0 2 
Tantima 0 0 0 0 
Tantoyuca 5                      38                          1 44 
Tempoal                    0 29 0 29 
Tuxpan                    0 498 10 508 
El Higo                                                         0                      26                          0               26 
Total                   8 963 16 987 
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Table 14. Total number of cases with result positive  at (SARS-CoV-2) COVID-19 
in the Huasteco from the Tantoyuca Area in Mexico as of August 1, 2020, 
according to status according to primary hospital care condition 
 in Intensive care unit 
 
 
 
Source: Own elaboration with Government of Information from the Mexico. 
Health Secretary. Epidemiological Surveillance System for Viral Respiratory 
Diseases as of August 1, 2020 
 
 
 
Figure 2 Comorbidities identified in hospitalized patients with a 
positive result for (SARS-CoV-2) COVID-19, in the  
Huasteco from the Tantoyuca Area in Mexico of August 1, 2020 
 
 
                                                                                                                                                                                                            Sex         Age 
 
                                                                                                                                                           Sex =1 Women, Sex = 2 Men 
 
Source: Own elaboration with Government of Information from 
the Mexico. Health Secretary. Epidemiological Surveillance 
System for Viral Respiratory Diseases as of August 1, 2020 
 
 
 
 
 
Municipality Intensive 
care unit 
Non  Intensive 
care unit 
Not  
specified 
Total 
     
Panuco 0 3 0 3 
Tantoyuca 0                        4                          0 4 
Total                    0 7 0 7 
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Map 1   Huasteco from the Tantoyuca Area 
 
Source: Own elaboration. 
With Catálogo de metadatos geográficos. Comisión Nacional para el Conocimiento y Uso de la 
Biodiversidad.  División política municipal, 1:250000. 2010. 
 
 
 
Declaration of Competing Interest 
 
The authors declare that they have no known competing financial interests or personal relationships 
which have, or could be perceived to have, influenced the work reported in this article. 
 
References 
 
[1]  Demsar J, Curk T, Erjavec A, Gorup C, Hocevar T, Milutinovic M, Mozina M, Polajnar M, Toplak M, 
Staric A, Stajdohar M, Umek L, Zagar L, Zbontar J, Zitnik M, Zupan B (2013) Orange: Data Mining Toolbox 
in Python, Journal of Machine Learning Research 14(Aug): 2349−2353. 
https://dl.acm.org/doi/pdf/10.5555/2567709.2567736 
 
[2] Government of Mexico. Health Secretary. Databases Covid-19 México. 
https://datos.gob.mx/busca/dataset/informacion-referente-a-casos-covid-19-en-mexico 
[3] Software Orange Data Mining version 3.26.1 https://orange.biolab.si 
  20 
[4] World Health Organization. (2020). Laboratory testing for coronavirus disease (COVID-19) in suspected 
human cases. Interim guidance. 19 March 2020. Recuperado de: https://www.who.int/publications-
detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117 
[5] Medel-Ramírez, Carlos and Medel-Lopez, Hilario, Data Mining for the Study of the Epidemic (SARS- 
CoV-2) COVID-19: Algorithm for the Identification of Patients (SARS-CoV-2) COVID 19 in Mexico (June 3, 
2020). Available at SSRN: https://ssrn.com/abstract=3619549 or http://dx.doi.org/10.2139/ssrn.3619549 
[6] INEGI, (2010). Catálogo de metadatos geográficos. Comisión Nacional para el Conocimiento y Uso de 
la Biodiversidad.  División política municipal, 1:250000. 2010. Palabras clave: 2010, Área Geoestadística, 
División, Límite, Municipios.  Fecha de publicación: 04-07-2011, del metadato 20-07-2017. Available at : 
http://www.conabio.gob.mx/informacion/gis/ 
Reference to a dataset: 
[7] Raw data can be retrieved from the Github repository https://github.com/CMedelR/dataCovid19/ 
 
 
 
 
